This is a community-generated profile. If you work at Arno Therapeutics, to claim it.
Arno Therapeutics Funding
$46M
33 rounds
Arno Therapeutics is active in the following markets / industries: biotechnology. The company has secured funding across 3 rounds, totaling in an amount of $46M. Their most recent funding was raised on October 30, 2013.
Funding Rounds
U
$31000000IPO
Undisclosed amountU
$15000000Investors of Arno Therapeutics
Commercial Capital
Rounds
U
Perceptive Advisors
Rounds
U
Marjorie Kaufman, CFA
Chairman of the Board, Undercover Colors. Advisory Board, Bio Capital Impact Fund. MBA @Chicago Booth, BA U. of Pennsylvania.
